Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ TADA3L Polyclonal Antibody

Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA540594
Description
Peptide sequence: AAVADKKKGL MGPLTELDTK DVDALLKKSE AQHEQPEDGC PFGALTQRLL Sequence homology: Cow: 100%; Dog: 100%; Guinea Pig: 100%; Horse: 100%; Human: 100%; Mouse: 100%; Rabbit: 100%; Rat: 100%; Zebrafish: 92%.
Many DNA-binding transcriptional activator proteins enhance the initiation rate of RNA polymerase II-mediated gene transcription by interacting functionally with the general transcription machinery bound at the basal promoter. Adaptor proteins are usually required for this activation, possibly to acetylate and destabilize nucleosomes, thereby relieving chromatin constraints at the promoter. The protein encoded by this gene is a transcriptional activator adaptor and has been found to be part of the PCAF histone acetylase complex. In addition, it associates with the tumor suppressor protein p53 and is required for full activity of p53 and p53-mediated apoptosis. At least four alternatively spliced variants have been found for this gene, but the full-length nature of some variants has not been determined.
Specifications
| TADA3L | |
| Polyclonal | |
| Unconjugated | |
| TADA3 | |
| 1110004B19Rik; ADA3; ADA3 homolog; ADA3-like protein; AI987856; alteration/deficiency in activation 3; fa03f04; FLJ20221; FLJ21329; hADA3; mADA3; NGG1; STAF54; Tada3; Tada3l; Transcriptional adapter 3; transcriptional adapter 3-like; transcriptional adaptor 3; transcriptional adaptor 3 (NGG1 homolog, yeast)-like; transcriptional adaptor 3-like isoform b; Unknown (protein for MGC:133915); wu:fa03f04; zgc:63596 | |
| Rabbit | |
| Affinity Chromatography | |
| RUO | |
| 10474 | |
| -20°C, Avoid Freeze/Thaw Cycles | |
| Liquid |
| Western Blot | |
| 0.5 mg/mL | |
| PBS with 2% sucrose and 0.09% sodium azide | |
| O75528 | |
| TADA3 | |
| Synthetic peptide directed towards the middle region of human TADA3L. | |
| 100 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction